Real-world incidence of endophthalmitis after intravitreal anti-VEGF injection: Common Data Model in ophthalmology
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world incidence of endophthalmitis after intravitreal anti-VEGF injection: Common Data Model in ophthalmology
Authors
Keywords
-
Journal
Epidemiology and Health
Volume -, Issue -, Pages e2021097
Publisher
Korean Society of Epidemiology
Online
2021-11-11
DOI
10.4178/epih.e2021097
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents
- (2020) Philip P. Storey et al. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE
- Analysis of antiseizure drug‐related adverse reactions from the electronic health record using the common data model
- (2020) Sun Ah Choi et al. EPILEPSIA
- Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
- (2019) Marc A Suchard et al. LANCET
- Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors
- (2018) Kunyong Xu et al. OPHTHALMOLOGY
- Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
- (2018) Jacqueline Corrigan-Curay et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti–Vascular Growth Factor Agents in a Nationwide Study in France
- (2018) Florian Baudin et al. JAMA Ophthalmology
- Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)
- (2017) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGICA
- Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
- (2017) Seth R Flaxman et al. Lancet Global Health
- Real-World Evidence — What Is It and What Can It Tell Us?
- (2016) Rachel E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Compounded Bevacizumab With Postinjection Endophthalmitis
- (2015) Brian L. VanderBeek et al. JAMA Ophthalmology
- Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)
- (2014) Ursula Schmidt-Erfurth et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership
- (2013) Paul E. Stang et al. ANNALS OF INTERNAL MEDICINE
- Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
- (2013) K Ghasemi Falavarjani et al. EYE
- Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors and outcomes
- (2012) D A M Lyall et al. EYE
- Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases
- (2012) Christian Reich et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage
- (2010) Hossein Nazari et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Serratia marcescens endophthalmitis associated with intravitreal injections of bevacizumab
- (2009) S H Lee et al. EYE
- Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy
- (2009) K Ghasemi Falavarjani et al. EYE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More